New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 3, 2014
10:42 EDTFBHS, THRX, LAMR, PETM, CBSO, TSM, LITB, SONS, WY, WLPHigh option volume stocks
High option volume stocks: FBHS WY SONS LITB TSM CBSO PETM LAMR THRX WLP
News For FBHS;WY;SONS;LITB;TSM;CBSO;PETM;LAMR;THRX;WLP From The Last 14 Days
Check below for free stories on FBHS;WY;SONS;LITB;TSM;CBSO;PETM;LAMR;THRX;WLP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 16, 2014
05:38 EDTTHRXGSK, Theravance initiate Phase III IMPACT study
GlaxoSmithKline (GSK) and Theravance (THRX) announced the start of a global phase III study, known as IMPACT, to evaluate the efficacy and safety of the 'closed' triple combination of FF/UMEC/VI in patients with chronic obstructive pulmonary disease, or COPD. IMPACT is the first pivotal phase III study in a programme to evaluate a once-daily closed triple combination treatment of an inhaled corticosteroid, or ICS; a long-acting muscarinic antagonist, or LAMA; and a long-acting beta2-adrenergic agonist, or LABA, in patients with COPD. The IMPACT study will enrol approximately 10,000 patients and assess whether the combination of FF, or fluticasone furoate, an ICS, UMEC, or umeclidinium, a LAMA, and VI, or vilanterol, a LABA, all delivered in GSK's Ellipta inhaler, can reduce the annual rate of moderate and severe exacerbations compared with two approved once daily COPD treatments, Relvar/Breo Ellipta, FF/VI, which is an ICS/LABA combination, and Anoro Ellipta, UMEC/VI, which is a LAMA/LABA combination.
July 15, 2014
10:37 EDTCBSOOptions with decreasing implied volatility
Subscribe for More Information
08:03 EDTCBSOCBS reports results of CBS Outdoor exchange offer
Subscribe for More Information
07:29 EDTTSMASML Q2 results could miss expectations, says RBC Capital
Subscribe for More Information
July 14, 2014
09:23 EDTWLPWellPoint Q2 EPS likely to beat consensus by 55c, says Sterne Agee
Subscribe for More Information
07:22 EDTWLPHealthcare Education Associates to hold a conference
4th Annual RISE California Summit to be held in San Diego on July 13-15.
July 11, 2014
16:46 EDTPETMStocks end week lower on European, Fed concerns
Subscribe for More Information
07:47 EDTPETMPetSmart unlikely to be acquired, says Oppenheimer
Subscribe for More Information
July 10, 2014
11:00 EDTCBSOHigh option volume stocks
High option volume stocks: CBS MEMP EWT CBSO DRWI TRW TTS EXK MEOH AG
08:56 EDTCBSOCBS announces preliminary results of CBS Outdoor exchange offer
Subscribe for More Information
07:54 EDTTSMTSMC begins shipping microprocessors to Apple, WSJ reports
TSMC (TSM) has begun shipping microprocessors to Apple (AAPL) for use in smartphones and tablets, reports the Wall Street Journal. According to people familiar with the matter, TSMC began shipping the microprocessors in Q2 and agreed to work together on more advanced chips next year. Reference Link
07:11 EDTWLPAetna, WellPoint top large-cap Managed Care picks at Jefferies
Jefferies calls Aetna (AET) and WellPoint (WLP) its favorite large-cap picks in the Managed Care space, with Health Net (HNT) its favored name in the small to mid-cap space. The firm believes the market is already expecting strong Q2 results from the sector, and it downgraded UnitedHealth (UNH) to Hold from Buy on valuation and below-peer earnings growth. Jefferies has Buy ratings on Aetna, Health Net, Molina Healthcare (MOH) and WellPoint.
06:23 EDTWLPHealth insurers moving away from fee for service model, NY Times reports
Subscribe for More Information
06:02 EDTPETMStocks with implied volatility below IV index mean; PETM BBBY
Subscribe for More Information
05:48 EDTCBSOStocks with implied volatility movement; CBSO MNKD
Subscribe for More Information
July 9, 2014
13:06 EDTPETMPetSmart downgraded to Hold from Buy at Standpoint Research
12:15 EDTPETMPetSmart merger with Petco would make sense, DealBook says
Subscribe for More Information
11:24 EDTCBSOHigh option volume stocks
High option volume stocks: GIMO NEPT BPOP AVAV CBSO LL BOBE KWK GNC TCS
06:47 EDTTHRXGlaxoSmithKline, Theravance announces Australia approval of Anoro Ellipta
Subscribe for More Information
06:15 EDTTSMTSMC to speed up development of 19nm process, DigiTimes reports
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use